Serum fibroblast growth factor 21 levels are positively associated with aortic arterial stiffness in patients with type 2 diabetes

被引：0
|
作者：
Hsu, B. -G. [1 ]
Chen, Y. -C [2 ]
Wu, D. -A. [3 ]
机构：
[1] Tzu Chi Gen Hosp, Hualien, Taiwan
[2] Dalin Tzu Chi Gen Hosp, Dept Psychiat, Chiayin, Taiwan
[3] Tzu Chi Gen Hosp, Div Metab & Endocrinol, Hualien, Taiwan
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1057
引用
收藏
页码：S517 / S518
页数：2
相关论文
共 50 条
  • [1] Serum Levels of Fibroblast Growth Factor 21 Are Positively Associated with Aortic Stiffness in Patients with Type 2 Diabetes Mellitus
    Huang, Sin-Yi
    Wu, Du-An
    Tsai, Jen-Pi
    Hsu, Bang-Gee
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (07)
  • [2] Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes
    Gao, Ruo-Yao
    Hsu, Bang-Gee
    Wu, Du-An
    Hou, Jia-Sian
    Chen, Ming-Chun
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
  • [3] Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
    Chiu, Liang-Te
    Hung, Chi-Di
    Lin, Lin
    Lin, Yu-Li
    Hsu, Bang-Gee
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2022, 2022
  • [4] Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes
    Yafei, Saeed
    Elsewy, Fathy
    Youssef, Eman
    Ayman, Mohammed
    El-Shafei, Mohamed
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 882 - 888
  • [5] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Yang Xiao
    Lingjiao Liu
    Aimin Xu
    Pengcheng Zhou
    Zhaofeng Long
    Yiting Tu
    Xiaoyan Chen
    Weili Tang
    Gan Huang
    Zhiguang Zhou
    [J]. Cardiovascular Diabetology, 14
  • [6] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Xiao, Yang
    Liu, Lingjiao
    Xu, Aimin
    Zhou, Pengcheng
    Long, Zhaofeng
    Tu, Yiting
    Chen, Xiaoyan
    Tang, Weili
    Huang, Gan
    Zhou, Zhiguang
    [J]. CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [7] SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS
    Panahi, Y.
    Bonakdaran, S.
    Yaghoubi, M. A.
    Keramati, M. R.
    Haratian, M.
    Sahebkar, A.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (03) : 257 - 261
  • [8] Association of Low Serum Adiponectin Levels with Aortic Arterial Stiffness in Patients with Type 2 Diabetes
    Shih, Cian-Huei
    Hsu, Bang-Gee
    Hou, Jia-Sian
    Wu, Du-An
    Subeq, Yi-Maun
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [9] SERUM FIBROBLAST GROWTH FACTOR 21 LEVELS ARE POSITIVELY ASSOCIATED WITH SKELETAL MUSCLE INDEX IN CHRONIC HEMODIALYSIS PATIENTS
    Chiu, Liang-Te
    Lin, Lin
    Tang, Chi-Chong
    Hsu, Bang-Gee
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 295 - 295
  • [10] Serum cystatin C is independently associated with aortic arterial stiffness in patients with type 2 diabetes
    Su, I-Min
    Wu, Du-An
    Lee, Chung-Jen
    Hou, Jia-Sian
    Hsu, Bang-Gee
    Wang, Ji-Hung
    [J]. CLINICA CHIMICA ACTA, 2018, 480 : 114 - 118
12345